What do you think?
Rate this book
White Market Drugs: Big Pharma and the Hidden History of Addiction in America
The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer’s Heroin to Purdue’s OxyContin and all the drugs in barbiturate “goof balls,” amphetamine “thrill pills,” the “love drug” Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls “white markets,” where legal drugs called medicines are sold to a largely white clientele.
These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its “drug wars”—until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America’s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction.
Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century.
By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself—ideas that have been failing us catastrophically for over a century.
These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its “drug wars”—until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America’s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction.
Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century.
By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself—ideas that have been failing us catastrophically for over a century.
400 pages, Hardcover
Published November 12, 2020
Ratings & Reviews
Friends & Following
Create a free account to discover what your friends think of this book!
Community Reviews
Displaying 1 - 11 of 11 reviews
September 7, 2020
If there had been a television in every home around WWI, there would have been a commercial that said “Ask your doctor if Heroin® is right for you.” Because Heroin was a registered, trademarked and readily available prescription drug from Bayer. All throughout the 20th century, drug companies were finding or inventing narcotics to swell their profits. In David Herzberg’s White Market Drugs, the history of legal drugs in America is that of solutions in search of problems, all while addicting and killing customers. If they made it, Americans would take it.
It is a history of failures. Government failed to regulate industry. Industry failed to provide safe products. Regulation caused the explosion of informal markets, where “dope fiends” could purchase illegal drugs from “peddlers”. And along the way, customers became addicts. They overdosed; they became criminals to raise cash for their addictions. The white markets were organized and legal, but they were populated with crooked doctors, crooked pharmacies and crooked manufacturers, making them no better than the black markets, where the working classes got their drugs. Herzberg positions it as three major drug crises, all of which were far worse than the illegal drug trade the government was (and is) constantly trying to stamp out. From opium and morphine, through barbiturates and (back to) opioids, Americans flock to their doctors and pharmacies in the white markets for their addictions. For those who can’t afford it, they flock to prison because of their purchases in the black markets. As Herzberg puts it: “Treating consumers like criminals…had been a self-fulfilling prophecy.”
The book is therefore not about marijuana, cocaine, amphetamines and ecstasy. It is about good, clean, authorized prescription drugs, addicting their users into poverty and death if prison doesn’t grab them first.
All through the book there are some disgusting commonalities. Drugmakers love hairsplitting. It was and is their way of differentiating themselves from the competition and from past failures. We are probably most familiar today with the hairsplitting over addiction. According to the makers of opioids, they are no longer addictive! This has been said repeatedly over the past 150 years, and it is no more true today than it was then, but they keep making this same false claim. And doctors keep falling for it.
The current malaise began in the 1980s, when researchers decided to split hairs over the addictiveness of opioids, in particular for oxycodone, a resurrected opioid from the 1940s. In denying the addictiveness of the drug, their studies instead said things like: “A set of aberrant behaviors marked by drug-craving, efforts to secure its supply, interference with physical health or psychosocial function, and recidivism after detoxification.” (But never addiction.) They called addiction to opioids “Pseudo-addiction” – it was a sign the patient needed more opioids! (But never addiction.)
Incredibly, the medical community bought into this obviously fake news, and doctors all over the country fell for the pitches of the sales reps from the opioid makers. My own dentist assured me it was a non-addictive pain killer when he prescribed oxycodone for me. Even though it didn’t pass the smell test.
This all came from the bizarre and misguided policies the government developed at the turn of the previous century. Opium and morphine were the fashionable drugs of the era. White women in particular sought solace in morphine. It combatted a make-believe illness doctors called neurasthenia – the stress of being a weak, delicate white woman in the Victorian era when women could do pretty much nothing but fret.
Congress and the government moved to split the pills in two; there were medicines and there were drugs. The medicines were to be regulated by the Food and Drug Administration (FDA), while drugs fell under the purview of the Federal Bureau of Narcotics (FBN). Didn’t matter that both compounds had their own medicinal properties, that customers couldn’t tell the difference between drugs and medicines, and that both could be obtained on the street regardless. For legal purposes, two whole bureaucracies were needed to keep them separate.
But in those days, there wasn’t much need of the street anyway. Doctors freely prescribed narcotics for all comers, starting with themselves. Many patients later claimed to have no idea what was in their meds. Even as laws were promulgated to control the distribution, huge prescribers of narcotics and huge purveyors (pharmacies) distributed them. A hundred years later, the USA once again found a Pareto distribution: 20% of the doctors did 80% of the prescribing of opioids, and 20% of pharmacies sold 80% of the pills. Even though they were both required to log their activities and even though they were required to report outsized quantities to the regulators, the money was just too good. Instead of reporting , they upsized to accommodate the demand.
Herzberg points to Demerol, a 1939 opioid that was entirely synthetic – the first of its kind. It was the first opioid not to be derived from opium. Winthrop, the drugmaker, claimed this made the drug non-addictive, and produced and sold massive amounts of it. It fought the government tooth and nail to keep the money pouring in. Its in-house magazine for sales reps touted not the efficacy, but rather the easy money it brought. It was not until 1962 that the FDA got the right to demand proof of efficacy for white market meds.
Although it is a very complex tale that Herzberg tells, there are some threads that flow all the way through. The drugmakers were always pushing to distribute more, without regard to need or harm. They were all over free samples of narcotics, even a hundred years ago. Anything to get someone hooked, starting with the doctor. They continually lied about the properties of the drugs. They fought off any kind of regulation. The drugs themselves were discoveries rather than purposeful. They were solutions in search of a problem. The drugmakers marketed them as the cure for all kinds of conditions that were simply not true. These all-purpose cure-alls went through little or no testing, not even for safety. Nonetheless, doctors bought in, hook, line and sinker.
Herzberg takes readers on a grand tour, explaining the development, marketing and effects of numerous drugs readers might or might not be familiar with. Their names are legion: opium, morphine, Heroin, codeine, Quaaludes, psychotropics, Dilaudid, Valium, Darvon, Demerol, Ritalin, methadone, OxyContin, Percodan, Darvon, Fentanyl and many others that could bring back fond memories for many Americans.
The federal government twisted and contorted itself in its efforts to control narcotics. In 1914 it passed the Harrison Act, which as was a tax law, not a narcotics law. It creatively required healthcare professionals to register and pay a tax on any narcotics they handled. Since only professionals could register, anyone in possession of narcotics who therefore could not have paid the tax was automatically a criminal for tax purposes. There were battles over interpretation, the usual spate of lawsuits, and a constant battering of its objectives and performance from within. Eventually, it seemed to have been simply outcompeted by new laws and agencies the government kept creating. For example, the government developed a bizarre benchmark: if a drug was less addictive than codeine, it would be regulated by the FDA. If it was more addictive than codeine, it would be regulated by the Harrison Act and the FBN. As Herzberg says, the government spent the 20th century arguing whether addiction was a disease or a crime. It was so contorted, the Sheriff of Alma Georgia admitted to taking narcotics, but by prescription, because he said, getting them from peddlers would be illegal.
With such confusion and doubt, gaps and loopholes big enough for caravans of drugs to drive through became the story of legal addiction in the USA.
There has just always been a white market for drugs that kill in the USA. Americans, Herzberg says, are drug-seeking rather than health-seeking. In 1954, barbiturates (for sleeping) were all the rage. They made up one in every six prescriptions (not including illegal otc sales which the FDA estimated brought them u to 50% of total sales). In the 1970s it was Valium, followed by Quaaludes. 5% of men and 10% of women were regularly using Valium in the early 1970s.
The whole business of the “War on Drugs” started by Nixon in the early 70s has been a horrific diversion of funds against a smaller black market, when right in front of everyone, the white markets were killing and continue to kill customers by the tens of thousands. Nixon was following in the steps of Lyndon Johnson, who began the new trail of pursuing illegal dealers and their customers instead of the big drugmakers and the doctors they compromised with their misinformation. “The history of American drug policy offers precious few success stories,” Herzberg says in an understatement worthy of Churchill. More realistically, he later calls it a white market apocalypse.
In a final touch of irony, the drug laws of the United States are so weak they could not stop makers like Purdue Pharma from producing, marketing and cashing in on opioids, fraudulently posing as non-addictive painkillers. Nonetheless, their customers went to prison. Doctors, pharmacists and patients continue to be sentenced to long prison terms for their roles in the disaster. The D.A.R.E. program in schools gets kids to snitch on their parents, putting them in prison and making the kids wards of the state, sent to foster homes where they are drugged to keep them passive. It is a suitably bizarre outcome for a perverse cobweb of rules and regulations targeting the wrong objectives, badly.
David Wineberg
It is a history of failures. Government failed to regulate industry. Industry failed to provide safe products. Regulation caused the explosion of informal markets, where “dope fiends” could purchase illegal drugs from “peddlers”. And along the way, customers became addicts. They overdosed; they became criminals to raise cash for their addictions. The white markets were organized and legal, but they were populated with crooked doctors, crooked pharmacies and crooked manufacturers, making them no better than the black markets, where the working classes got their drugs. Herzberg positions it as three major drug crises, all of which were far worse than the illegal drug trade the government was (and is) constantly trying to stamp out. From opium and morphine, through barbiturates and (back to) opioids, Americans flock to their doctors and pharmacies in the white markets for their addictions. For those who can’t afford it, they flock to prison because of their purchases in the black markets. As Herzberg puts it: “Treating consumers like criminals…had been a self-fulfilling prophecy.”
The book is therefore not about marijuana, cocaine, amphetamines and ecstasy. It is about good, clean, authorized prescription drugs, addicting their users into poverty and death if prison doesn’t grab them first.
All through the book there are some disgusting commonalities. Drugmakers love hairsplitting. It was and is their way of differentiating themselves from the competition and from past failures. We are probably most familiar today with the hairsplitting over addiction. According to the makers of opioids, they are no longer addictive! This has been said repeatedly over the past 150 years, and it is no more true today than it was then, but they keep making this same false claim. And doctors keep falling for it.
The current malaise began in the 1980s, when researchers decided to split hairs over the addictiveness of opioids, in particular for oxycodone, a resurrected opioid from the 1940s. In denying the addictiveness of the drug, their studies instead said things like: “A set of aberrant behaviors marked by drug-craving, efforts to secure its supply, interference with physical health or psychosocial function, and recidivism after detoxification.” (But never addiction.) They called addiction to opioids “Pseudo-addiction” – it was a sign the patient needed more opioids! (But never addiction.)
Incredibly, the medical community bought into this obviously fake news, and doctors all over the country fell for the pitches of the sales reps from the opioid makers. My own dentist assured me it was a non-addictive pain killer when he prescribed oxycodone for me. Even though it didn’t pass the smell test.
This all came from the bizarre and misguided policies the government developed at the turn of the previous century. Opium and morphine were the fashionable drugs of the era. White women in particular sought solace in morphine. It combatted a make-believe illness doctors called neurasthenia – the stress of being a weak, delicate white woman in the Victorian era when women could do pretty much nothing but fret.
Congress and the government moved to split the pills in two; there were medicines and there were drugs. The medicines were to be regulated by the Food and Drug Administration (FDA), while drugs fell under the purview of the Federal Bureau of Narcotics (FBN). Didn’t matter that both compounds had their own medicinal properties, that customers couldn’t tell the difference between drugs and medicines, and that both could be obtained on the street regardless. For legal purposes, two whole bureaucracies were needed to keep them separate.
But in those days, there wasn’t much need of the street anyway. Doctors freely prescribed narcotics for all comers, starting with themselves. Many patients later claimed to have no idea what was in their meds. Even as laws were promulgated to control the distribution, huge prescribers of narcotics and huge purveyors (pharmacies) distributed them. A hundred years later, the USA once again found a Pareto distribution: 20% of the doctors did 80% of the prescribing of opioids, and 20% of pharmacies sold 80% of the pills. Even though they were both required to log their activities and even though they were required to report outsized quantities to the regulators, the money was just too good. Instead of reporting , they upsized to accommodate the demand.
Herzberg points to Demerol, a 1939 opioid that was entirely synthetic – the first of its kind. It was the first opioid not to be derived from opium. Winthrop, the drugmaker, claimed this made the drug non-addictive, and produced and sold massive amounts of it. It fought the government tooth and nail to keep the money pouring in. Its in-house magazine for sales reps touted not the efficacy, but rather the easy money it brought. It was not until 1962 that the FDA got the right to demand proof of efficacy for white market meds.
Although it is a very complex tale that Herzberg tells, there are some threads that flow all the way through. The drugmakers were always pushing to distribute more, without regard to need or harm. They were all over free samples of narcotics, even a hundred years ago. Anything to get someone hooked, starting with the doctor. They continually lied about the properties of the drugs. They fought off any kind of regulation. The drugs themselves were discoveries rather than purposeful. They were solutions in search of a problem. The drugmakers marketed them as the cure for all kinds of conditions that were simply not true. These all-purpose cure-alls went through little or no testing, not even for safety. Nonetheless, doctors bought in, hook, line and sinker.
Herzberg takes readers on a grand tour, explaining the development, marketing and effects of numerous drugs readers might or might not be familiar with. Their names are legion: opium, morphine, Heroin, codeine, Quaaludes, psychotropics, Dilaudid, Valium, Darvon, Demerol, Ritalin, methadone, OxyContin, Percodan, Darvon, Fentanyl and many others that could bring back fond memories for many Americans.
The federal government twisted and contorted itself in its efforts to control narcotics. In 1914 it passed the Harrison Act, which as was a tax law, not a narcotics law. It creatively required healthcare professionals to register and pay a tax on any narcotics they handled. Since only professionals could register, anyone in possession of narcotics who therefore could not have paid the tax was automatically a criminal for tax purposes. There were battles over interpretation, the usual spate of lawsuits, and a constant battering of its objectives and performance from within. Eventually, it seemed to have been simply outcompeted by new laws and agencies the government kept creating. For example, the government developed a bizarre benchmark: if a drug was less addictive than codeine, it would be regulated by the FDA. If it was more addictive than codeine, it would be regulated by the Harrison Act and the FBN. As Herzberg says, the government spent the 20th century arguing whether addiction was a disease or a crime. It was so contorted, the Sheriff of Alma Georgia admitted to taking narcotics, but by prescription, because he said, getting them from peddlers would be illegal.
With such confusion and doubt, gaps and loopholes big enough for caravans of drugs to drive through became the story of legal addiction in the USA.
There has just always been a white market for drugs that kill in the USA. Americans, Herzberg says, are drug-seeking rather than health-seeking. In 1954, barbiturates (for sleeping) were all the rage. They made up one in every six prescriptions (not including illegal otc sales which the FDA estimated brought them u to 50% of total sales). In the 1970s it was Valium, followed by Quaaludes. 5% of men and 10% of women were regularly using Valium in the early 1970s.
The whole business of the “War on Drugs” started by Nixon in the early 70s has been a horrific diversion of funds against a smaller black market, when right in front of everyone, the white markets were killing and continue to kill customers by the tens of thousands. Nixon was following in the steps of Lyndon Johnson, who began the new trail of pursuing illegal dealers and their customers instead of the big drugmakers and the doctors they compromised with their misinformation. “The history of American drug policy offers precious few success stories,” Herzberg says in an understatement worthy of Churchill. More realistically, he later calls it a white market apocalypse.
In a final touch of irony, the drug laws of the United States are so weak they could not stop makers like Purdue Pharma from producing, marketing and cashing in on opioids, fraudulently posing as non-addictive painkillers. Nonetheless, their customers went to prison. Doctors, pharmacists and patients continue to be sentenced to long prison terms for their roles in the disaster. The D.A.R.E. program in schools gets kids to snitch on their parents, putting them in prison and making the kids wards of the state, sent to foster homes where they are drugged to keep them passive. It is a suitably bizarre outcome for a perverse cobweb of rules and regulations targeting the wrong objectives, badly.
David Wineberg
September 1, 2020
Thank you to the publisher and Netgalley for the opportunity to read and review this book. This was VERY informative on the addiction crisis we are in right now. It is just so amazing how pharmaceuticals are seen as something good, but can lead you down a very bad path.
March 29, 2025
By and far the most educational book I’ve read on America’s historical drug crisis. 1000% recommend if you’re even a little bit interested in learning more about how we arrived to our current policy approach.
September 6, 2026
arranged by Gemini
歷史學者 David Herzberg 在其著作 [White Market Drugs: Big Pharma and the Hidden History of Addiction in America] 中，揭開了美國藥物成癮史上長期被掩蓋的雙軌體系。公眾普遍認為 21 世紀的鴉片類藥物危機是突如其來的現代悲劇，但作者指出，這只是美國一個多世紀以來「合法成癮市場」反覆重演的最新一幕。
---
### 一、 本書核心精華要點
**1. 「白色市場」（White Markets）與「非正規黑市」的雙軌體制**
* **人為劃分的邊界**：百年來美國將成癮性精神物質硬生生拆解為兩種平行的流通體系——一種是由藥廠研發、醫師開立、藥局販售的合法處方藥，即**白色市場（White Market）**；另一種則是走私、街頭交易的違禁品，即**黑市（Black/Informal Market）**。
* **階級與種族偏見**：這種劃分並非基於藥理學毒性或成癮強度，而是階級與種族的投射。白色市場主要服務具備醫療保險、有社會地位的白人中產階級；而黑市則多與有色人種及貧困底層掛鉤，成為治安嚴打的目標。
**2. 歷史的三波浪潮：換湯不換藥的成癮循環**
* **第一波（19 世紀末至 20 世紀初）**：嗎啡（Morphine）與拜耳藥廠（Bayer）推出的合法海洛因（Heroin），被廣泛開給受「神經衰弱」困擾的中產階級女性。
* **第二波（20 世紀中葉）**：紅中、白板等巴比妥類安眠藥（Barbiturates）、減肥用的安非他命（Amphetamines），以及 1970 年代的「母親的小幫手」安定文（Valium）和安眠酮（Quaalude）。這些藥物在家庭主婦與上班族間氾濫成災，全由合法處方取得。
* **第三波（1990 年代至今）**：普渡製藥（Purdue Pharma）的奧斯康定（OxyContin）與各類強效合成鴉片類藥物，以「絕不成癮、改善生活品質」的醫療包裝席捲全美。
**3. 藥廠的語言遊戲與偽科學行銷**
* **文字遊戲推卸責任**：每當一種處方藥成癮問題爆發，藥廠便會研發「新型、無成癮性」的替代品，宣稱分子結構改良徹底解決了成癮問題（如歷史上的待美羅 Demerol、奧斯康定）。
* **發明「假性成癮」（Pseudo-addiction）**：藥廠甚至收買學界，宣稱病患出現強烈渴藥、焦慮或失控服藥行為不是「成癮」，而是「止痛劑量不足引起的假性成癮」，藉此誘導醫師加倍開立藥物。
**4. 監管失靈：把「利潤」當作危險藥物的分配機制**
* **利益驅動公衛崩壞**：資本主義醫藥體系的根本缺陷，在於允許以「追求利潤最大化」為目標的跨國藥廠來支配具備高度成癮性的物質。
* **柏拉圖法則（80/20 法則）**：統計顯示，20% 的不肖診所（Pill Mills）與 20% 的藥局開出並販賣了全美 80% 的處方鴉片類藥物。即使有申報機制，龐大的暴利讓醫療人員與藥廠選擇共同忽視安全警訊。
**5. 禁毒戰爭的諷刺與自證預言**
* **雙重標準**：美國政府發動的「毒品戰爭」（War on Drugs），動用重刑、特警部隊監禁黑市中的街頭吸毒者；但造成更多死亡的白色市場成癮者，卻被視為「無辜的醫療受害者」。
* **制度逼入絕境**：當政府終於收緊處方藥監管，缺乏妥善戒癮支持的患者迅速陷入戒斷痛苦，不得不轉向黑市尋求更危險的街頭海洛因與非法芬太尼。
---
### 二、 書中名言佳句與深度醒思
* **「現代鴉片危機並非前所未見的意外，它只是這場橫跨一個多世紀、合法藥品成癮長劇中的最新一章。」**
*醒思：若不檢視整個處方藥行銷與資本結構的系統性根源，每一代人都會被新型的合法成癮藥物所吞噬。*
* **「將消費者當作罪犯對待，向來只是一場自證預言。」**
*醒思：將成癮問題推給治安懲罰，只會驅使成癮者走向地下化、邊緣化與過量死亡，無助於解決公共衛生危機。*
* **「藥廠最擅長的把戲就是字眼拆解（Hairsplitting）——他們一次又一次宣稱這款新藥不會成癮，而醫學界也一次又一次全盤買單。」**
*醒思：以「止痛」之名的科學包裝，本質上往往只是新瓶裝舊酒的商業促銷話術。*
* **「利潤，是用來組織與分配成癮性藥物時最糟糕的原則。」**
*醒思：成癮物質具有天生的「重複購買驅動力」，放任資本市場主導必然導致過度供應與公衛災難。*
---
### 三、 結合當前最新醫學與公衛研究比對
Herzberg 在書中提出的政策剖析與歷史批判，與近年國際權威醫學期刊（如《The Lancet》、《JAMA Psychiatry》）及公衛機構的最新監測數據高度吻合，且近年醫學界在應對成癮危機上呈現了進一步的轉變：
| 議題面向 | 《White Market Drugs》書中論述 | 最新醫學文獻與臨床公衛實證 |
| --- | --- | --- |
| **危機演變（危機階段論）** | 處方藥氾濫（白色市場）是誘發危機的源頭，管制收緊後成癮者被迫轉向街頭黑市。 | 美國 CDC 與醫學研究將危機細分為四波：第一波為**處方鴉片藥物**，第二波為**街頭海洛因**，第三波為**非法合成芬太尼（Fentanyl）**，目前正處於第四波——**芬太尼混合興奮劑（如冰毒 Methamphetamine、甲苯噻嗪 Xylazine 獸用鎮靜劑）**。這完全印證了作者所警告的「切斷處方供應卻無配套戒癮治療，會迫使病患流向更致命黑市」的推論。 |
| **成癮治療策略** | 主張捨棄道德與刑事懲戒，轉向**消費者保護（Consumer Protection）與醫療減害**。 | 《Lancet》成癮委員會最新共識指出，傳統要求完全戒斷（Abstinence-only）復發率極高。目前醫學黃金標準為**藥物輔助治療（MOUD）**，如丁基原啡因（Buprenorphine）與美沙冬（Methadone），研究證實其能降低過量死亡率達 50% 以上；同時普及其解毒劑**納洛酮（Naloxone/Narcan）**作為非處方急救藥物。 |
| **疼痛管理神經科學** | 批評醫療界過度將強效鴉片類藥物視為各類慢性疼痛的唯一萬靈丹。 | 最新神經病理學研究強調**中樞敏化（Central Sensitization）**機制，證實長期使用高劑量鴉片類藥物反而會引發「鴉片類藥物誘導痛覺過敏（OIH）」。臨床指引大幅下修慢性非癌性疼痛的處方建議，轉向非鴉片類藥物、物理治療與多模式認知行為治療（CBT）。 |
| **大藥廠法律與制度責任** | 藥廠長期鑽監管空子，靠虛假宣傳與政治遊說規避法規制裁。 | 近年美國司法體系通過了歷史性的「全國鴉片類藥物和解協議（National Opioid Settlements）」，總金額突破 500 億美元，普渡製藥（薩克勒家族）、連鎖藥局（CVS、Walgreens）與經銷商均面臨法律責任與天價罰金，資金強制指定用於地方公共衛生戒癮與預防專案。 |
| **結構性健康不平等** | 白色市場受種族與階級庇護，有色人種被排斥在正規醫療之外但遭重刑懲罰。 | 近年公衛統計揭示更殘酷的趨勢：隨著芬太尼滲透街頭毒品市場，非裔與美洲原住民的過量致死率成長速度已顯著超越白人族群，同時這些社群在取得高品質成癮治療藥物（如 Buprenorphine）的門檻仍然顯著高於白人患者。 |
---
### 總結
《White Market Drugs》打破了「街頭毒品 vs. 救命醫藥」的虛妄二分法。結合當前醫學與公衛研究的視野來看，解決現代成癮危機的根本途徑，不在於發動更多的治安掃蕩，而是**徹底重組藥品監管機制**——終結利潤驅動的成癮物質推銷，將成癮真正視為一種慢性神經與生物心理疾病，並為所有階層的患者建立易於取得、具尊嚴且有實證支持的減害與醫療支持體系。
歷史學者 David Herzberg 在其著作 [White Market Drugs: Big Pharma and the Hidden History of Addiction in America] 中，揭開了美國藥物成癮史上長期被掩蓋的雙軌體系。公眾普遍認為 21 世紀的鴉片類藥物危機是突如其來的現代悲劇，但作者指出，這只是美國一個多世紀以來「合法成癮市場」反覆重演的最新一幕。
---
### 一、 本書核心精華要點
**1. 「白色市場」（White Markets）與「非正規黑市」的雙軌體制**
* **人為劃分的邊界**：百年來美國將成癮性精神物質硬生生拆解為兩種平行的流通體系——一種是由藥廠研發、醫師開立、藥局販售的合法處方藥，即**白色市場（White Market）**；另一種則是走私、街頭交易的違禁品，即**黑市（Black/Informal Market）**。
* **階級與種族偏見**：這種劃分並非基於藥理學毒性或成癮強度，而是階級與種族的投射。白色市場主要服務具備醫療保險、有社會地位的白人中產階級；而黑市則多與有色人種及貧困底層掛鉤，成為治安嚴打的目標。
**2. 歷史的三波浪潮：換湯不換藥的成癮循環**
* **第一波（19 世紀末至 20 世紀初）**：嗎啡（Morphine）與拜耳藥廠（Bayer）推出的合法海洛因（Heroin），被廣泛開給受「神經衰弱」困擾的中產階級女性。
* **第二波（20 世紀中葉）**：紅中、白板等巴比妥類安眠藥（Barbiturates）、減肥用的安非他命（Amphetamines），以及 1970 年代的「母親的小幫手」安定文（Valium）和安眠酮（Quaalude）。這些藥物在家庭主婦與上班族間氾濫成災，全由合法處方取得。
* **第三波（1990 年代至今）**：普渡製藥（Purdue Pharma）的奧斯康定（OxyContin）與各類強效合成鴉片類藥物，以「絕不成癮、改善生活品質」的醫療包裝席捲全美。
**3. 藥廠的語言遊戲與偽科學行銷**
* **文字遊戲推卸責任**：每當一種處方藥成癮問題爆發，藥廠便會研發「新型、無成癮性」的替代品，宣稱分子結構改良徹底解決了成癮問題（如歷史上的待美羅 Demerol、奧斯康定）。
* **發明「假性成癮」（Pseudo-addiction）**：藥廠甚至收買學界，宣稱病患出現強烈渴藥、焦慮或失控服藥行為不是「成癮」，而是「止痛劑量不足引起的假性成癮」，藉此誘導醫師加倍開立藥物。
**4. 監管失靈：把「利潤」當作危險藥物的分配機制**
* **利益驅動公衛崩壞**：資本主義醫藥體系的根本缺陷，在於允許以「追求利潤最大化」為目標的跨國藥廠來支配具備高度成癮性的物質。
* **柏拉圖法則（80/20 法則）**：統計顯示，20% 的不肖診所（Pill Mills）與 20% 的藥局開出並販賣了全美 80% 的處方鴉片類藥物。即使有申報機制，龐大的暴利讓醫療人員與藥廠選擇共同忽視安全警訊。
**5. 禁毒戰爭的諷刺與自證預言**
* **雙重標準**：美國政府發動的「毒品戰爭」（War on Drugs），動用重刑、特警部隊監禁黑市中的街頭吸毒者；但造成更多死亡的白色市場成癮者，卻被視為「無辜的醫療受害者」。
* **制度逼入絕境**：當政府終於收緊處方藥監管，缺乏妥善戒癮支持的患者迅速陷入戒斷痛苦，不得不轉向黑市尋求更危險的街頭海洛因與非法芬太尼。
---
### 二、 書中名言佳句與深度醒思
* **「現代鴉片危機並非前所未見的意外，它只是這場橫跨一個多世紀、合法藥品成癮長劇中的最新一章。」**
*醒思：若不檢視整個處方藥行銷與資本結構的系統性根源，每一代人都會被新型的合法成癮藥物所吞噬。*
* **「將消費者當作罪犯對待，向來只是一場自證預言。」**
*醒思：將成癮問題推給治安懲罰，只會驅使成癮者走向地下化、邊緣化與過量死亡，無助於解決公共衛生危機。*
* **「藥廠最擅長的把戲就是字眼拆解（Hairsplitting）——他們一次又一次宣稱這款新藥不會成癮，而醫學界也一次又一次全盤買單。」**
*醒思：以「止痛」之名的科學包裝，本質上往往只是新瓶裝舊酒的商業促銷話術。*
* **「利潤，是用來組織與分配成癮性藥物時最糟糕的原則。」**
*醒思：成癮物質具有天生的「重複購買驅動力」，放任資本市場主導必然導致過度供應與公衛災難。*
---
### 三、 結合當前最新醫學與公衛研究比對
Herzberg 在書中提出的政策剖析與歷史批判，與近年國際權威醫學期刊（如《The Lancet》、《JAMA Psychiatry》）及公衛機構的最新監測數據高度吻合，且近年醫學界在應對成癮危機上呈現了進一步的轉變：
| 議題面向 | 《White Market Drugs》書中論述 | 最新醫學文獻與臨床公衛實證 |
| --- | --- | --- |
| **危機演變（危機階段論）** | 處方藥氾濫（白色市場）是誘發危機的源頭，管制收緊後成癮者被迫轉向街頭黑市。 | 美國 CDC 與醫學研究將危機細分為四波：第一波為**處方鴉片藥物**，第二波為**街頭海洛因**，第三波為**非法合成芬太尼（Fentanyl）**，目前正處於第四波——**芬太尼混合興奮劑（如冰毒 Methamphetamine、甲苯噻嗪 Xylazine 獸用鎮靜劑）**。這完全印證了作者所警告的「切斷處方供應卻無配套戒癮治療，會迫使病患流向更致命黑市」的推論。 |
| **成癮治療策略** | 主張捨棄道德與刑事懲戒，轉向**消費者保護（Consumer Protection）與醫療減害**。 | 《Lancet》成癮委員會最新共識指出，傳統要求完全戒斷（Abstinence-only）復發率極高。目前醫學黃金標準為**藥物輔助治療（MOUD）**，如丁基原啡因（Buprenorphine）與美沙冬（Methadone），研究證實其能降低過量死亡率達 50% 以上；同時普及其解毒劑**納洛酮（Naloxone/Narcan）**作為非處方急救藥物。 |
| **疼痛管理神經科學** | 批評醫療界過度將強效鴉片類藥物視為各類慢性疼痛的唯一萬靈丹。 | 最新神經病理學研究強調**中樞敏化（Central Sensitization）**機制，證實長期使用高劑量鴉片類藥物反而會引發「鴉片類藥物誘導痛覺過敏（OIH）」。臨床指引大幅下修慢性非癌性疼痛的處方建議，轉向非鴉片類藥物、物理治療與多模式認知行為治療（CBT）。 |
| **大藥廠法律與制度責任** | 藥廠長期鑽監管空子，靠虛假宣傳與政治遊說規避法規制裁。 | 近年美國司法體系通過了歷史性的「全國鴉片類藥物和解協議（National Opioid Settlements）」，總金額突破 500 億美元，普渡製藥（薩克勒家族）、連鎖藥局（CVS、Walgreens）與經銷商均面臨法律責任與天價罰金，資金強制指定用於地方公共衛生戒癮與預防專案。 |
| **結構性健康不平等** | 白色市場受種族與階級庇護，有色人種被排斥在正規醫療之外但遭重刑懲罰。 | 近年公衛統計揭示更殘酷的趨勢：隨著芬太尼滲透街頭毒品市場，非裔與美洲原住民的過量致死率成長速度已顯著超越白人族群，同時這些社群在取得高品質成癮治療藥物（如 Buprenorphine）的門檻仍然顯著高於白人患者。 |
---
### 總結
《White Market Drugs》打破了「街頭毒品 vs. 救命醫藥」的虛妄二分法。結合當前醫學與公衛研究的視野來看，解決現代成癮危機的根本途徑，不在於發動更多的治安掃蕩，而是**徹底重組藥品監管機制**——終結利潤驅動的成癮物質推銷，將成癮真正視為一種慢性神經與生物心理疾病，並為所有階層的患者建立易於取得、具尊嚴且有實證支持的減害與醫療支持體系。
December 18, 2024
This book was highly recommended by a professor as an introduction to drug policy. There is so much here. As Herzberg makes clear, the distinctions between white markets and informal markets, drugs and medicines, and the legal frameworks that govern them have always been socially constructed—shaped by politics, race, class, and gender, rather than science. Herzberg meticulously traces the history of white markets, starting with the widespread use of morphine in the late 19th century. He highlights how "respectable white patients" were given under-the-table maintenance therapy, while those who used opium or heroin were criminalized and forced to seek out informal markets. This dynamic—where some substances are classified as medicine and others as drugs—also allowed pharmaceutical companies to peddle barbiturates, amphetamines, and minor sedatives throughout the 20th century to the same "respectable white patients," concealing the addictive potential of these drugs and setting the stage for major public health crises. Meanwhile, informal markets were increasingly stigmatized and racialized. In example after example, Herzberg makes clear that profit is a terrible organizing principle for addictive drugs. The most successful drug controls are designed not to punish consumers into abstaining from drug use but to curtail the pharmaceutical industry’s profit-driven motives through strong regulatory oversight and consumer protections.
January 26, 2025
For me this was an interesting topic told in Far too much detail, much of it repetitive (how many times do we hear about Kolb, Anslinger...) and ultimately boring, a pity because the message is a good one. Some of the reviews here capture the essence in 1 page. David apparently spent 10y writing the book, a third of a working life! I guess there are no real surprises about the duplicity of Big Pharma but how all this locks together was interesting, if tooo long in the telling. The diagrams in the Appendix should have been in the text
Read
March 25, 2021read for history of drugs course !
January 8, 2023
Informative book, but at the same time, not so entertaining.
February 27, 2024
Very boring historical record of pharmaceutical drug markets and informal drug markets
February 27, 2024
A very well written and easy to read history of the evolution of American pharmacology, drugs, and medicine through a regulatory and political policy lens
March 6, 2024
Boring but that’s bc I don’t like history. Otherwise well written and good info!
Displaying 1 - 11 of 11 reviews